Related Content
Search Google Scholar for:
|
|
Science 8 May 1992: Vol. 256. no. 5058, pp. 789 - 794 DOI: 10.1126/science.256.5058.789
|
|
Articles
Science, Vol 256, Issue 5058, 789-794
Copyright © 1992 by American Association for the Advancement of Science
Malignant hyperthermia
DH MacLennan
and
MS Phillips
Banting & Best Department of Medical Research, University of Toronto, Ontario, Canada.
In humans genetically predisposed to malignant hyperthermia, anesthesia can induce skeletal muscle rigidity, hypermetabolism, and high fever, which, if not immediately reversed, can lead to tissue damage or death. The corresponding condition in swine leads to stress-induced deaths and devalued meat products. Abnormalities in the Ca2+ release channel of skeletal muscle sarcoplasmic reticulum (the ryanodine receptor) have been implicated in the cause of both the porcine and human syndromes by physiological and biochemical studies and genetic linkage analysis. In swine, a single founder mutation in the ryanodine receptor gene (RYR1) can account for all cases of malignant hyperthermia in all breeds, but a series of different RYR1 mutations are likely to be uncovered in human families with MH. Moreover, lack of linkage between malignant hyperthermia and RYR1 in some families indicates a heterogeneous genetic basis for the human syndrome.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- Pale poultry muscle syndrome.
- D. P. Smith and J. K. Northcutt (2009)
Poult. Sci.
88, 1493-1496
| Abstract »
| Full Text »
| PDF »
- A retrograde signal from RyR1 alters DHP receptor inactivation and limits window Ca2+ release in muscle fibers of Y522S RyR1 knock-in mice.
- Z. Andronache, S. L. Hamilton, R. T. Dirksen, and W. Melzer (2009)
PNAS
106, 4531-4536
| Abstract »
| Full Text »
| PDF »
- Inactivation of UCP1 and the Glycerol Phosphate Cycle Synergistically Increases Energy Expenditure to Resist Diet-induced Obesity.
- R. Anunciado-Koza, J. Ukropec, R. A. Koza, and L. P. Kozak (2008)
J. Biol. Chem.
283, 27688-27697
| Abstract »
| Full Text »
| PDF »
- Reduced Threshold for Luminal Ca2+ Activation of RyR1 Underlies a Causal Mechanism of Porcine Malignant Hyperthermia.
- D. Jiang, W. Chen, J. Xiao, R. Wang, H. Kong, P. P. Jones, L. Zhang, B. Fruen, and S. R. W. Chen (2008)
J. Biol. Chem.
283, 20813-20820
| Abstract »
| Full Text »
| PDF »
- Zebrafish relatively relaxed mutants have a ryanodine receptor defect, show slow swimming and provide a model of multi-minicore disease.
- H. Hirata, T. Watanabe, J. Hatakeyama, S. M. Sprague, L. Saint-Amant, A. Nagashima, W. W. Cui, W. Zhou, and J. Y. Kuwada (2007)
Development
134, 2771-2781
| Abstract »
| Full Text »
| PDF »
- Malignant Hyperthermia Following Systemic Rewarming After Hypothermic Cardiopulmonary Bypass.
- A. D. Lichtman and C. Oribabor (2006)
Anesth. Analg.
102, 372-375
| Abstract »
| Full Text »
| PDF »
- Malignant hyperthermia.
- K. G. Allman and l. H. Wilson (2006)
Oxford Handbook of Anaesthesia
2, med-9780198566090-div1-10
| Full Text »
- 3,4-Methylenedioxymethamphetamine (Ecstasy) Activates Skeletal Muscle Nicotinic Acetylcholine Receptors.
- W. Klingler, J. J. A. Heffron, K. Jurkat-Rott, G. O'Sullivan, A. Alt, F. Schlesinger, J. Bufler, and F. Lehmann-Horn (2005)
J. Pharmacol. Exp. Ther.
314, 1267-1273
| Abstract »
| Full Text »
| PDF »
- Ca2+ Signaling in HEK-293 and Skeletal Muscle Cells Expressing Recombinant Ryanodine Receptors Harboring Malignant Hyperthermia and Central Core Disease Mutations.
- M. Brini, S. Manni, N. Pierobon, G. G. Du, P. Sharma, D. H. MacLennan, and E. Carafoli (2005)
J. Biol. Chem.
280, 15380-15389
| Abstract »
| Full Text »
| PDF »
- Effect of Ryanodine Receptor Mutations on Interleukin-6 Release and Intracellular Calcium Homeostasis in Human Myotubes from Malignant Hyperthermia-susceptible Individuals and Patients Affected by Central Core Disease.
- S. Ducreux, F. Zorzato, C. Muller, C. Sewry, F. Muntoni, R. Quinlivan, G. Restagno, T. Girard, and S. Treves (2004)
J. Biol. Chem.
279, 43838-43846
| Abstract »
| Full Text »
| PDF »
- Scanning for Mutations of the Ryanodine Receptor (RYR1) Gene by Denaturing HPLC: Detection of Three Novel Malignant Hyperthermia Alleles.
- A. Tammaro, A. Bracco, S. Cozzolino, M. Esposito, A. Di Martino, G. Savoia, L. Zeuli, G. Piluso, S. Aurino, and V. Nigro (2003)
Clin. Chem.
49, 761-768
| Abstract »
| Full Text »
| PDF »
- Clinical and functional effects of a deletion in a COOH-terminal lumenal loop of the skeletal muscle ryanodine receptor.
- F. Zorzato, N. Yamaguchi, L. Xu, G. Meissner, C. R. Muller, P. Pouliquin, F. Muntoni, C. Sewry, T. Girard, and S. Treves (2003)
Hum. Mol. Genet.
12, 379-388
| Abstract »
| Full Text »
| PDF »
- Extending the Skeletal Muscle Viability Period in the Malignant Hyperthermia Test.
- S. Bina, S. Holman, and S. M. Muldoon (2003)
Anesth. Analg.
96, 153-158
| Abstract »
| Full Text »
| PDF »
- Phenotyping malignant hyperthermia susceptibility by measuring halothane-induced changes in myoplasmic calcium concentration in cultured human skeletal muscle cells.
- T. Girard, S. Treves, K. Censier, C. R. Mueller, F. Zorzato, and A. Urwyler (2002)
Br. J. Anaesth.
89, 571-579
| Abstract »
| Full Text »
| PDF »
- B-lymphocytes from Malignant Hyperthermia-susceptible Patients Have an Increased Sensitivity to Skeletal Muscle Ryanodine Receptor Activators.
- T. Girard, D. Cavagna, E. Padovan, G. Spagnoli, A. Urwyler, F. Zorzato, and S. Treves (2001)
J. Biol. Chem.
276, 48077-48082
| Abstract »
| Full Text »
| PDF »
- Identification of four novel mutations in the C-terminal membrane spanning domain of the ryanodine receptor 1: association with central core disease and alteration of calcium homeostasis.
- N. Tilgen, F. Zorzato, B. Halliger-Keller, F. Muntoni, C. Sewry, L. M. Palmucci, C. Schneider, E. Hauser, F. Lehmann-Horn, C. R. Muller, et al. (2001)
Hum. Mol. Genet.
10, 2879-2887
| Abstract »
| Full Text »
| PDF »
- Excitation-contraction uncoupling by a human central core disease mutation in the ryanodine receptor.
- G. Avila, J. J. O'Brien, and R. T. Dirksen (2001)
PNAS
98, 4215-4220
| Abstract »
| Full Text »
| PDF »
- Malignant hyperthermia mutation Arg615Cys in the porcine ryanodine receptor alters voltage dependence of Ca2+ release.
- B Dietze, J Henke, H M Eichinger, F Lehmann-Horn, and W Melzer (2000)
J. Physiol.
526, 507-514
| Abstract »
| Full Text »
| PDF »
- Calcium Ion in Skeletal Muscle: Its Crucial Role for Muscle Function, Plasticity, and Disease.
- M. W. Berchtold, H. Brinkmeier, and M. Muntener (2000)
Physiol Rev
80, 1215-1265
| Abstract »
| Full Text »
| PDF »
- A novel ryanodine receptor mutation and genotype-phenotype correlation in a large malignant hyperthermia New Zealand Maori pedigree.
- R. L. Brown, A. N. Pollock, K. G. Couchman, M. Hodges, D. O. Hutchinson, R. Waaka, P. Lynch, T. V. McCarthy, and K. M. Stowell (2000)
Hum. Mol. Genet.
9, 1515-1524
| Abstract »
| Full Text »
| PDF »
- Contribution of Autosomal Loci and the Y Chromosome to the Stress Response in Rats.
- P. Dumas, Z. Pausova, V. Kren, D. Krenova, M. Pravenec, M. Dumont, D. Ely, M. Turner, Y. Sun, J. Tremblay, et al. (2000)
Hypertension
35, 568-573
| Abstract »
| Full Text »
| PDF »
- A Multicenter Study of 4-Chloro-m-cresol for Diagnosing Malignant Hyperthermia Susceptibility.
- C. P. Baur, L. Bellon, P. Felleiter, M. Fiege, R. Fricker, K. Glahn, J. J. A. Heffron, A. Herrmann-Frank, K. Jurkat-Rott, W. Klingler, et al. (2000)
Anesth. Analg.
90, 200
| Abstract »
| Full Text »
| PDF »
- A Postulated Role of the Near Amino-terminal Domain of the Ryanodine Receptor in the Regulation of the Sarcoplasmic Reticulum Ca2+ Channel.
- R. El-Hayek, Y. Saiki, T. Yamamoto, and N. Ikemoto (1999)
J. Biol. Chem.
274, 33341-33347
| Abstract »
| Full Text »
| PDF »
- Suramin and Suramin Analogs Activate Skeletal Muscle Ryanodine Receptor via a Calmodulin Binding Site.
- M. Klinger, M. Freissmuth, P. Nickel, M. Stäbler-Schwarzbart, M. Kassack, J. Suko, and M. Hohenegger (1999)
Mol. Pharmacol.
55, 462-472
| Abstract »
| Full Text »
- Modification of excitation-contraction coupling by 4-chloro-m-cresol in voltage-clamped cut muscle fibres of the frog (R. pipiens).
- A Struk and W Melzer (1999)
J. Physiol.
515, 221-231
| Abstract »
| Full Text »
| PDF »
- Mutation screening of the RYR1 gene and identification of two novel mutations in Italian malignant hyperthermia families.
- V. Barone, O. Massa, E. Intravaia, A. Bracco, A. Di Martino, V. Tegazzin, S. Cozzolino, and V. Sorrentino (1999)
J. Med. Genet.
36, 115-118
| Abstract »
| Full Text »
- Measurement of Resting Cytosolic Ca2+ Concentrations and Ca2+ Store Size in HEK-293 Cells Transfected with Malignant Hyperthermia or Central Core Disease Mutant Ca2+ Release Channels.
- J. Tong, T. V. McCarthy, and D. H. MacLennan (1999)
J. Biol. Chem.
274, 693-702
| Abstract »
| Full Text »
| PDF »
- The Cytoplasmic Loops between Domains II and III and Domains III and IV in the Skeletal Muscle Dihydropyridine Receptor Bind to a Contiguous Site in the Skeletal Muscle Ryanodine Receptor.
- P. Leong and D. H. MacLennan (1998)
J. Biol. Chem.
273, 29958-29964
| Abstract »
| Full Text »
| PDF »
- A 37-Amino Acid Sequence in the Skeletal Muscle Ryanodine Receptor Interacts with the Cytoplasmic Loop between Domains II and III in the Skeletal Muscle Dihydropyridine Receptor.
- P. Leong and D. H. MacLennan (1998)
J. Biol. Chem.
273, 7791-7794
| Abstract »
| Full Text »
| PDF »
- Prolonged exposure to halothane and associated changes in carbohydrate metabolism in rat muscles in vivo.
- L. D. M. C.-B. Ferreira, T. N. Palmer, and P. A. Fournier (1998)
J Appl Physiol
84, 1470-1474
| Abstract »
| Full Text »
| PDF »
- Caffeine and Halothane Sensitivity of Intracellular Ca2+ Release Is Altered by 15 Calcium Release Channel (Ryanodine Receptor) Mutations Associated with Malignant Hyperthermia and/or Central Core Disease.
- J. Tong, H. Oyamada, N. Demaurex, S. Grinstein, T. V. McCarthy, and D. H. MacLennan (1997)
J. Biol. Chem.
272, 26332-26339
| Abstract »
| Full Text »
| PDF »
- Anesthesiology- First of Two Parts.
- R. A. Wiklund and S. H. Rosenbaum (1997)
N. Engl. J. Med.
337, 1132-1141
| Full Text »
| PDF »
- Ion Channels -- Molecular Divining Rods Hit Their Clinical Mark.
- E. P. Hoffman and K. Gardner (1997)
N. Engl. J. Med.
336, 1599-1600
| Full Text »
- The Sarcoplasmic Reticulum Ca2+ Channel/Ryanodine Receptor: Modulation by Endogenous Effectors, Drugs and Disease States.
- R. Zucchi and S. Ronca-Testoni (1997)
Pharmacol. Rev.
49, 1-52
| Abstract »
| Full Text »
| PDF »
- Mouse models of human disease. Part II: recent progress and future directions..
- M A Bedell, D A Largaespada, N A Jenkins, and N G Copeland (1997)
Genes & Dev.
11, 11-43
| PDF »
- Mutational Analysis of the Ligand Binding Site of the Inositol 1,4,5-Trisphosphate Receptor.
- F. Yoshikawa, M. Morita, T. Monkawa, T. Michikawa, T. Furuichi, and K. Mikoshiba (1996)
J. Biol. Chem.
271, 18277-18284
| Abstract »
| Full Text »
| PDF »
- Regulation of Tissue-specific Expression of the Skeletal Muscle Ryanodine Receptor Gene.
- S. Schmoelzl, T. Leeb, H. Brinkmeier, G. Brem, and B. Brenig (1996)
J. Biol. Chem.
271, 4763-4769
| Abstract »
| Full Text »
| PDF »
- Identification of Dantrolene Binding Sites in Porcine Skeletal Muscle Sarcoplasmic Reticulum.
- J. Parness and S. S. Palnitkar (1995)
J. Biol. Chem.
270, 18465-18472
| Abstract »
| Full Text »
| PDF »
- Pharmacogenetics: Its Place in Medicine and Biology.
- W. Kalow (1992)
Journal of Pharmacy Practice
5, 312-316
| Abstract »
| PDF »
- Molecular Cloning, Expression, Functional Characterization, Chromosomal Localization, and Gene Structure of Junctate, a Novel Integral Calcium Binding Protein of Sarco(endo)plasmic Reticulum Membrane.
- S. Treves, G. Feriotto, L. Moccagatta, R. Gambari, and F. Zorzato (2000)
J. Biol. Chem.
275, 39555-39568
| Abstract »
| Full Text »
| PDF »
|
|